Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Cadence Design Systems
CDNS
$87.9B
| $73.3M | 0.11% |
1,153,929
-1,541,810
| -57% | -$81.7M |
|
227
Westlake Corp
WLK
$10.1B
| $73.1M | 0.11% |
1,077,131
+243,107
| +29% | +$17.6M |
|
228
PUT
iShares Biotechnology ETF
IBB
$10.7B
| $72.8M | 0.11% |
651,100
+109,900
| +20% | +$12.1M |
|
229
Ryman Hospitality Properties
RHP
$8.86B
| $72.3M | 0.11% |
878,824
+785,240
| +839% | +$62.7M |
|
230
Antero Resources
AR
$11.7B
| $72.2M | 0.11% |
8,178,148
+2,625,330
| +47% | +$24.8M |
|
|
CTXS
231
DELISTED
Citrix Systems Inc
CTXS
| $72M | 0.11% |
722,113
-215,984
| -23% | -$22.4M |
|
|
CLR
232
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $71.8M | 0.11% |
1,604,057
+1,456,184
| +985% | +$65.1M |
|
|
AGN
233
DELISTED
Allergan plc
AGN
| $71.8M | 0.11% |
490,389
+455,798
| +1,318% | +$66.1M |
|
|
HDS
234
DELISTED
HD Supply Holdings, Inc.
HDS
| $71.6M | 0.11% |
1,652,328
+1,153,781
| +231% | +$48.1M |
|
235
CALL
Range Resources
RRC
$9.59B
| $70.9M | 0.11% |
6,310,100
-931,700
| -13% | -$10.1M |
|
236
CALL
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$137M
| $70.8M | 0.11% |
+37,792
| New | +$83.3M |
|
237
Take-Two Interactive
TTWO
$44.8B
| $70.6M | 0.11% |
748,566
+421,303
| +129% | +$40.8M |
|
238
GE Aerospace
GE
$361B
| $70.4M | 0.11% |
1,414,331
+644,350
| +84% | +$30.3M |
|
239
PUT
State Street Technology Select Sector SPDR ETF
XLK
$120B
| $70.3M | 0.11% |
1,900,000
+1,192,200
| +168% | +$40.8M |
|
240
PUT
Intel
INTC
$476B
| $69.9M | 0.1% |
1,302,300
+486,600
| +60% | +$24.7M |
|
|
PRMW
241
DELISTED
Primo Water Corporation
PRMW
| $69.9M | 0.1% |
4,786,618
+15,229
| +0.3% | +$229K |
|
242
Trane Technologies
TT
$99.8B
| $69.7M | 0.1% |
645,276
-311,718
| -33% | -$31.6M |
|
243
Crown Holdings
CCK
$13B
| $69.6M | 0.1% |
1,276,324
+919,076
| +257% | +$47.4M |
|
|
NVRO
244
DELISTED
NEVRO CORP.
NVRO
| $69.4M | 0.1% |
1,110,912
-30,167
| -3% | -$1.42M |
|
245
Texas Instruments
TXN
$241B
| $69M | 0.1% |
650,420
-972,637
| -60% | -$101M |
|
246
Teleflex
TFX
$5.88B
| $68.8M | 0.1% |
227,624
+196,218
| +625% | +$54.7M |
|
247
Jack in the Box
JACK
$331M
| $68.3M | 0.1% |
843,206
-255,419
| -23% | -$20.4M |
|
248
McKesson
MCK
$100B
| $68.2M | 0.1% |
582,569
-32,193
| -5% | -$3.97M |
|
|
ISBC
249
DELISTED
Investors Bancorp, Inc.
ISBC
| $67.8M | 0.1% |
5,718,540
+4,241,333
| +287% | +$51.1M |
|
250
Las Vegas Sands
LVS
$30.5B
| $67.5M | 0.1% |
1,107,745
-785,389
| -41% | -$46.2M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.